Skip to main content

Table 1 Patient overview in all 78 patients

From: High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection

FactorsAll patients (n = 78)
Age (y.o.)69 (39–87)
Gender (Male / Female)47 / 31
Neoadjuvant therapy36
 Chemotherapy25
 Chemoradiotherapy11
PTPE18
Type of liver resectiona
 No liver resection (PD, Extra bile duct resection)5
 S1,5,6,7,827
 S1,4,5,6,7,87
 S1,2,3,426
 S1,2,3,4,5,85
 Others8
Histological type: G1 / G2 / G3 / others49 / 18 / 9 / 2
TNM (UICC 8th)
 pT: T0 / T1 / T2 / T3 / T41 / 8 / 33 / 12 / 24
 pN: N0 / N1 or N240 / 38
 M1 (Intrahepatic / Extrahepatic)6 (3 / 3)
Residual tumor status: R0 / R1 / R253 / 14 / 11
Postoperative hospital stay (median: days)45.5 (13–325)
Complication ≥ C-D grade III32
Postoperative chemotherapy56
  1. PTPE percutaneous transhepatic portal vein embolization, PD pancreaticoduodenectomy, C-D Clavien-Dindo
  2. aExpressed as Couinaud’s hepatic segments resected
\